Home › Trial NCT06440616
Benefit of Spectral Information in Patients Suspected for Lung Cancer
- Trial IDNCT06440616
- StatusRecruiting
- PhaseN/A
- Study typeInterventional
- SponsorCopenhagen University Hospital at Herlev
- Enrollment1000
- Start date2024-05-24
- ConditionsLung Neoplasm Malignant
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.